NEW YORK (AP) — Democratic National Committee Chair Ken Martin released a critical study of the party's performance in the 2024 campaign on Thursday, bowing to intense internal pressure from ...

Democratic National Committee Chair Ken Martin on Thursday released the party’s autopsy report on the 2024 election after facing intense pressure to do so. Subscribe to read this story ad-free Get ...

Since Donald Trump won a second term as U.S. president in 2024, unsubstantiated claims that the election was "stolen" and that former Vice President Kamala Harris was the rightful winner have ...

For the most part, voting patterns across demographic groups in the 2024 presidential election were not substantially different from the 2020 and 2016 elections. But Donald Trump’s gains among several ...

The composition of Republican and Democratic voters in the United States has changed since the 2020 presidential election, and the shifts have been even larger since the 2016 contest. Donald Trump’s ...

National health expenditures are projected to have grown 8.2 percent in 2024 and to increase 7.1 percent in 2025, reflecting continued strong growth in the use of health care services and goods.

2024 started off immediately with some of the best K-dramas dropping at the beginning of the year. There were action-packed, supernatural, and definitely some romantic comedies, setting the tone for ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A legal case questioning the accuracy of the 2024 election is moving ...

For stock investors, 2024 was an expectedly great year. Behind the continued bull market for stocks was solid economic growth, falling inflation, Federal Reserve interest-rate cuts, and healthy ...

Over-reliance on JavaScript creates a blind spot for AI search crawlers. AI search crawlers reportedly can't read JavaScript, limiting your site's visibility. Server-side rendering and HTML-first ...

Amid another year of solid performance in the stock market, AppLovin APP performed best in the Morningstar US Large-Mid Cap Index. The mobile app technology company surged over 700% in 2024 after ...

The FDA’s Center for Drug Evaluation and Research (CDER) approved 50 new small molecules, biologics and oligonucleotide therapeutics last year. The class of 2024 was a little smaller than that of 2023 ...